http://www.mymedicalcareer.com.au/news/ en Copyright 2010 Mon, 04 Jan 2010 11:20:41 +1000 http://www.sixapart.com/movabletype/ http://blogs.law.harvard.edu/tech/rss BIT’s 2nd Annual International Congress of Cardiology ICC 2010 Theme:Translational Medicine to Healthcare Time:December 7-9, 2010 Place:Shanghai, China Website:http://www.bitlifesciences.com/icc2010/ Description of the Conference: In the wake of ICC-2009, on behalf of the organizing committee of ICC2010, I am honored to announce that BIT's 2nd International Congress of Cardiology (ICC) will be held during December 7-9, 2010, Shanghai, China. Which will have 10 chapters and about 150 sessions. On December 5-7, 2009, the 1st International Congress of Cardiology (ICC-2009) was held successfully in Shanghai, China. Nearly 200 experts take part in the opening ceremony. Dr. Xiaodan Mei, the Executive Chairman of this event delivered the opening remarks to welcome all our participants. And four keynote speakers of Dr. C. Richard Conti, professor from University of Florida, Dr. Daniel Loisance, professor from Henri Mondor Hospital, Dr. Dan J. Fintel, professor from Feinberg School of Medicine and Dr. John Shryock, senior director from Gilead Sciences shared their research and made splendid speeches. During the conference, nearly 150 speakers make their contribution to it. Highlights: • 500+ Targeted Audiences from all Over the World • 400+ Scientific/Tech and Business Presentations • 200+ Posters/Exhibition Booths for Development and Collaborations in Cardiology Field • Tailored Dynamic Round Table Network for Business and Market Development as Requested • Exciting Tech Tour to Xi' an Name of Tracks: ICC Chapter 1: Clinical Cardiology and Disease Management Chapter 2: Cardiac Imaging and Molecular Diagnosis Chapter 3: Electrophysiology and Pacing Chapter 4: Interventional Cardiology and Translational Cardiology Chapter 5: Basic Science and Emerging Technologies Chapter 6: Cardiovascular Drug Discovery and Development Chapter 7: Preventive Cardiology, Nutrition, Life Style and Alternative Medicine Chapter 8: Community Cardiology: Nursing, Hospice and Palliative Care, and Health Promotion Chapter 9: Industrial Sciences and Technologies Chapter 10: Educational Training Courses Total Number of Sessions 148 Expected Number of Speakers 400 Target Participants Cardiology Professionals Clinical Manufacturers R&D Scientists Industrial Executives Healthcare Workers http://www.mymedicalcareer.com.au/news/2010/01/bit-2nd-annual-international-c/ http://www.mymedicalcareer.com.au/news/2010/01/bit-2nd-annual-international-c/ News & Events Mon, 04 Jan 2010 11:20:41 +1000 Theme Voice of Virologists Time July 31-August 3, 2010 Place BEXCO, Busan, South Korea Website http://www.bitlifesciences.com/wcvi2010 Description of the Conference The 1st World Congress of Virus and Infections is the extension of the previous two annual World Summits of Antivirals. There are 3 parallel symposia at this congress: 1st World Congress of Virus and Infections, 1st Annual Inaugurate Symposium of Hepatitis Virus and 3rd Annual World Summit of Antivirals. WCVI 2010 will set World Summit of Antivirals as the essence, arrange a unique symposium for hepatitis virus and enlarge its involvement in animal and plant antivirals. There is also a large poster session arranged for young scientists to have them heard by the worldwide professionals. Highlights 3 Parallel sub-conferences of more than 150 remarkable sessions 1000 scientific and technological posters to share the new findings and breakthroughs 500-800 parallel presentations and discussions on update current novel R & D status 100-150 exhibitors to demonstrate their products and technology development 100 Showcases for most promising and fast growing companies in antiviral R & D Special tailored 1 to 1 network for business and collaboration demands Name of Tracks WCVI Track 1: Global Epidemics and Prevention Track 2: General Virology and Basic Sciences Track 3: Medical and Clinical Virology Track 4: Retrovirus-HIV/AIDS-Basic Sciences and Implications Track 5: Other Retrovirus Researches Track 6: Respiratory and Emerging/Re-emerging Viruses Track 7: Neuro-Viorology Track 8: Pediatric Viral Infectious Diseases Track 9: Human Tumor Virology Track 10: Viral Immunology, Infection and Immunity Track 11: Agriculture and Plant Virology Track 12: Veterinary Virology SHV Track 1: Hepatitis A and E Virus Track 2: Hepatitis B and D Virus Track 3: Hepatisis C Virus Track 4: Virus and Liver Cancer WSA Track 1: Targeting Drug Discovery and Development-Small Molecules Track 2: Antiviral Vaccine Development Track 3: Immunotherapy and Therapeutic Antibodies Track 4: Gene Therapy for Viral Infections Contact Information : Sponsorship & Media Partners Ms. Chris Huang Program Coordinator Email: chris@bit-wsa.com Organizing Committee of WCVI-2010, China 26 Gaoneng Street, Room 405, Dalian High-tech Zone, Dalian, LN 116025, China Tel: 0086-411-84799609-803 Fax: 0086-411-84799629 http://www.mymedicalcareer.com.au/news/2009/12/bits-1st-world-congress-of-vir/ http://www.mymedicalcareer.com.au/news/2009/12/bits-1st-world-congress-of-vir/ News & Events Mon, 28 Dec 2009 17:56:04 +1000 Time: June 22-25, 2010 Venue: Singapore EXPO, Singapore Theme: Health Science without Borders Website: http://www.bitlifesciences.com/cancer2010/ After the outstanding success of the last two conferences in Shanghai and Beijing, China, which was attended by over 600 eminent scientists and 1000 participants every time, the third congress in Singapore promises to be an even larger event emphasizes on the practical, actionable ideas for accelerating the cancer research and therapy. Plenary, concurrent, poster sessions and exhibition focusing on the full spectrum of latest research will be helpful for all delegates from academia and industry to deeply understand the novel technologies and current situation in cancer field. In next conference 2010, over 600 global specialists are anticipated to get together to present and share their cutting-edge developments and up-to-date researches in medical research, Innovation Technologies, pathogenesis, diagnostics, prevention, treatment and clinical research of all various kinds of cancer. Also we are convinced WCC-2010 will definitely offer an idea platform of promotion and collaboration for relevant companies and institutes with their technologies, products and services. WCC-2010 consists of 10 Scientific Tracks, panel discussions, free communications, poster presentations, and Exhibition booths that will cover all the main oncological aspects and will give you the opportunity to be updated in all the sectors in cancer sciences. Scientific Program at a Glance Track 1: Medical Research on Major Cancers Track 2: Basic Sciences in Cancer Research Track 3: Innovation Technologies in Cancer Research Track 4: Anti-Cancer Drug Discovery and Development Track 5: Clinical Diagnostics, Therapy and Clinical Update Track 6: Lung Cancer Symposium Track 7: Cancer Nursing, Support Care and Public Health Track 8: Cancer Prevention and Complimentary Therapy Track 9: Industrial Leaders’ Science Symposium in Cancer Research Track 10: Bio Venture Capital Forum on Oncology Lying almost on the equator, Singapore is the most developed city-state in the southeast of Asia but it is carefully stage-managed combination of Western modernity and treasured Eastern and colonial past that makes Singapore such an accessible slice of Asia. In the crowded streets of Chinatown, fortune tellers, calligraphers and temple worshippers are still a part of everyday life. In Little India, you can buy the best sari material, freshly ground spices or a picture of your favorite Hindu god. In the small shops of Arab Street, the cry of the imam can be heard from the nearby Sultan Mosque. It is our personal wish and hope that the congress participants will thoroughly enjoy the scientific and social program as well as the atmosphere of beautiful Singapore. For more information, PS: http://www.bitlifesciences.com/cancer2010/ Look forward to your reply! Nancy Jiang Organizing Commission of WCC-2010 BIT Life Sciences, Inc. 26 Gaoneng St., F4 Dalian Hightech Zone Dalian, LN 116025, China Tel: 0086-411-84799609—803 Fax: 0086-411-84799629 Email: nancy@cancercon.com Website at: http://www.bitlifesciences.com/cancer2010/ http://www.mymedicalcareer.com.au/news/2009/12/bits-3rd-world-cancer-congress/ http://www.mymedicalcareer.com.au/news/2009/12/bits-3rd-world-cancer-congress/ News & Events Mon, 28 Dec 2009 17:51:07 +1000 Theme: From Nervous Functions to Treatment Time: June 25-28, 2010 Place: Singapore EXPO, Singapore Website:http://www.bitlifesciences.com/neurotalk2010/default.asp Description of the Conference The mission of NeuroTalk-2010 is to initiate a sustainable platform for exchanging up-to-the-minute upstream and downstream achievements, industrial needs and research opportunities of Neurosciences fields in Asia Pacific Rim, to promote neuroscience, increase communication and facilitate collaboration between investigators throughout the world. Here, neuroscientists, neurologists and neurosurgeons will bring us the extraordinary advances on the treatment of injuries and illnesses affecting the brain, spine and nervous system. This focused event pays tribute to the growing significance of neurosciences, we cordially welcome you to join us and witness the advances in neurosciences together! Highlights: 6 Main Tracks focusing on new advances of neurosciences Organize up to 400+ Oral Presentations to supply a broad view of research 300+ Posters and 100 Company Exhibitions 1000+ Attendees To accelerate progress in the development of neurosciences Gain valuable career development advice/knowledge Tech tour to famous science spots & historical sites in Singapore. Name of Tracks: Track 1: Basic Research of Neurosciences -Scientific Foundation for Understanding Mechanisms Track 2: Novel Technologies & Medical Devices for Neuro Disorders -Applied Innovations for better Diseases Studies and Controls Track 3: Medical Research of Neurodegenerative Diseases -From Development to Human Behaviors Track 4: Anti-Neurodegenerative Drug Discovery & Development -From the Bench to the Bedside Track 5: Diagnostics, Therapeutics and Clinical Management -Applying Right Ways to Rescue Lives Track 6: Business Development in Neuroscience Industries -Translation of Cutting Edge Technology into Industrialization. Contact Information: Ms. Kelly Wang Organizing Commission of NeuroTalk-2010 26 Gaoneng St., F4 Dalian Hightech Zone Dalian, LN 116025, China Tel: 0086-411-84799624 Fax: 0086-411-84799629 Email: kelly@bitlifesciences.com http://www.mymedicalcareer.com.au/news/2009/12/bits-1st-annual-world-congress/ http://www.mymedicalcareer.com.au/news/2009/12/bits-1st-annual-world-congress/ News & Events Mon, 28 Dec 2009 17:46:22 +1000 BIT’s 8th Annual Congress of International Drug Discovery Science and Technology (IDDST) Theme: Supporting Systems for Major Innovative Drugs Time: October 23-26, 2010 Venue: Beijing International Convention Center, Beijing, China Website: http://www.iddst.com/iddst2010/ Dear Sir/Ms, BIT Life Sciences and Organizing Committee are organizing the 8th Annual Congress of International Drug Discovery Science and Technology (IDDST) as part of their dedication to offer professionals in drug discovery filed a multidisciplinary platform to learn about the latest scientific updates and current industry standards. The congress with the theme “Supporting Systems for Major Innovative Drugs” will be held during October 23-26, 2010, Beijing International Convention Center, Beijing, China. Shanghai China. On behalf of organizing committee, we’re pleased to network and explore partnering opportunities. The IDDST congress is initiated by BIT Life Sciences in 2003, with 7 years’ contribution in the field of drug discovery and development, it has became a leading international event for the professionals to pinpoint and identify opportunities and market needs, explore Asian demand and get updated on latest breakthroughs in drug R&D. IDDST 2010 emphasizes on the practical, actionable ideas for accelerating pre-clinical and clinical drug discovery and drug therapy. Plenary, concurrent, poster sessions and exhibition focusing on the full spectrum of latest research will be helpful for all delegates from academia and industry to deeply understand the market and current situation on drug discovery and on new therapeutics. It will provide a platform for all pharmaceutical scientists, clinicians and manufacturers to get updated on latest breakthroughs in drug R&D areas and new therapeutics. After the overwhelming success of seven years’ contribution in drug discovery and development, the 8th congress will promise to be a much grand event with 600 talks and 120 dynamical sessions, poster presentations and an associated commercial exhibition For IDDST 2010, BIT Life Sciences is pleased to design 10 chapters for the participants: Chapter 1: Basic Sciences and Technologies of Drug Discovery Chapter 2: Emerging Technologies and Key Tech Platform Infrastructure for Drug Discovery Chapter 3: Advances in Anti-Major Disease Drug R & D Chapter 4: Smart Medicinal Chemistry toward NCEs Chapter 5: Innovations and Improvement of Major Biotherapeutics Chapter 6: Tech-Upgrade of Key Drugs & Biosimilar Products Chapter 7: Scientifically Upgrading Key Chinese Traditional Medicines Chapter 8: Translational Medicine and Globalization Strategies Chapter 9: Professional Industrial Incubators for Drug Innovations Chapter 10: International Partnering, Integrative Services and Investment for Drug Discovery In addition to the outstanding program, you will be able to enjoy the culture and sights of Beijing, the capital of China. Beijing is at its best in late spring and autumn. Autumn is a particularly pleasant time to visit as the days are warm and the leaves of the many trees in the city turn glorious shades, and we encourage you to extend your trip and get to know the rest of China as well. We look forward to seeing you in Beijing for a stimulating and enjoyable conference. Kindest regards, Amy Zhou Organizing Committee of IDDST 2010, BIT Life Sciences, Inc. 26 Gaoneng St. Dalian Hightech Zone Dalian, LN 116025, China Tel: 0086-411-84799609-801 Fax: 0086-411-84799629 Email: amy@iddst.com http://www.mymedicalcareer.com.au/news/2009/12/bits-8th-annual-congress-of-in/ http://www.mymedicalcareer.com.au/news/2009/12/bits-8th-annual-congress-of-in/ News & Events Mon, 28 Dec 2009 17:41:07 +1000 The AICT meeting in 2010 will showcase the basics and the latest advances in coronary intervention technology in the form of live demonstrations by renowned operators, as well as didactic lectures and interactive sessions with experts. http://www.mymedicalcareer.com.au/news/2009/10/6th-asian-interventional-cardi/ http://www.mymedicalcareer.com.au/news/2009/10/6th-asian-interventional-cardi/ News & Events Wed, 28 Oct 2009 15:09:08 +1000 In the Search for the right job, as a jobseeker you can spend a lot of time on Job Boards searching through mountains of jobs, often poorly catalogued, and usually posted by Recruitment Agencies. Very few jobs are directly with the employer and are typically difficult to locate. To overcome all these obstacles, Apply Direct has created a world first, Next Generation Job Search tool. This Next Generation Job Search tool collects and catalogues thousands of jobs, directly from each employer’s website, onto a single website. The employers are from all levels of the public sector, private sector, non-profit and volunteer organisations. The benefits to job seekers include: * Saving valuable time by being able to search through thousands of direct Employer job listings on a single website; * Less frustration by achieving job search results that actually match the search criteria (we use highly skilled HR and Recruitment experts to catalogue all jobs prior to entry on the site); * The Relief of not having to deal with any Recruitment Agents - you won’t find any Agency jobs on our site! Apply Direct currently list the jobs for hundreds of Australian employers and continuously add more employers and jobs. At the time of posting this news article there are 8752 jobs nationwide which includes 934 jobs in the Medical/Healthcare industry http://www.applydirect.com.au/jobs/Medical-Nursing-Healthcare/all-subtypes/all-states/all-cities plus Graduate roles as well http://www.applydirect.com.au/jobs/Graduate/Medical-Nursing-and-Healthcare/all-states/all-cities http://www.mymedicalcareer.com.au/news/2009/10/medical-careers-advanced-job-s-1/ http://www.mymedicalcareer.com.au/news/2009/10/medical-careers-advanced-job-s-1/ News & Events Thu, 15 Oct 2009 08:00:30 +1000 AMA (NSW) clinical conference for 2010 is being held in BRUGES, Belgium with an optional Pre-conference tour (23-28 April)of the SOMME BATTLEFIELDS including ANZAC DAY SERVICE at Villers-Bretonneux. Durring the conference 28 April-03 May 2010 delegates will stay at the Crowne Plaza Hotel in Bruges. Speakers at the conference include: Dr Christine Jenkins – Respiratory Dr Sally McCarthy – Emergency Medicine Dr Greg Nelson – Cardiology Prof Peter Thursby – Vascular Other topics to be covered include medico-legal issues, financial management and practice management sessions For further information visit: http://www.medicaltoursaustralia.com.au OR http://www.nswama.com.au http://www.mymedicalcareer.com.au/news/2009/10/2010-ama-nsw-clinical-conferen/ http://www.mymedicalcareer.com.au/news/2009/10/2010-ama-nsw-clinical-conferen/ News & Events Mon, 12 Oct 2009 11:30:04 +1000

The Australian Government will provide $275 million over 4 years to general practice infrastructure across Australia with the rollout of 31 General Practice Super Clinics.

One of the core objectives of these Super Clinics is to support medical education.

Several studies have demonstrated that the major barriers to teaching in general practice are time, space and money.

We argue that General Practice Super Clinics can provide a responsive, flexible work culture; and improved payment and targeted resources to support the need for increased teaching capacity, and to attract and retain workforce for general practice and primary care.

]]> http://www.mymedicalcareer.com.au/news/2009/10/general-practice-super-clinics/ http://www.mymedicalcareer.com.au/news/2009/10/general-practice-super-clinics/ News & Events general practice super clinics training Tue, 06 Oct 2009 10:56:52 +1000 An association with excellence should be reserved for educational institutions which verify that their actions make a difference to people's well-being. The graduates they produce should not only possess all of the competencies desirable to improve the health of citizens and society, but should also use them in their professional practice. Four principles enunciated by the World Health Organization refer to the type of health care to which people have a right, from both an individual and a collective standpoint: quality, equity, relevance and effectiveness. Therefore, social, economic, cultural and environmental determinants of health must guide the strategic development of an educational institution.]]> http://www.mymedicalcareer.com.au/news/2009/10/social-accountability-and-accr/ http://www.mymedicalcareer.com.au/news/2009/10/social-accountability-and-accr/ News & Events education social accountability univerisities Tue, 06 Oct 2009 10:43:36 +1000 Dear Friends and Colleagues, We extend a warm welcome to the leading scientists, doctors, industrialists and young researchers to BIT Life Sciences’ 1st Annual World Congress of Immunodiseases and Therapy 2010 (WCIT-2010) with the theme of “Boosting Health and Vitality”, which will take place in Beijing, China on May 15-17, 2010. The congress starts at 9:00 and finishes at 17:00. With your great contributions in the study and research on immunology, you are expected to take part in this international and compositive conference. The program track info at the bottom of the e-mail is for your reference. WCIT is a focused conference to present and deliberate the advances in immunology, which is significant, timely and important to the health of humanity. The well selected topics cover across disciplinary breaking, from concept to therapy. It is anticipated over 500 global specialists to get together to present and share their cutting-edge technologies and up-to-date researches in an innovative and invigorating combination of presentations, symposia, discussions, panel discussion sessions and associated young scientist poster sessions along with exhibition of technology and new products. The comprehensive and intellectually stimulating scientific program of the first annual will embrace a broad spectrum of topics in basic science, medical research, diagnosis, prevention, clinical treatment and therapy of immune diseases. We believe that WCIT-2010 will definitely provide you an ideal platform for promoting ground breaking research and seeding potential collaborations for relevant parties of tailored interests not only in R & D areas but also the industrial and medical sectors. The Initiative of WCIT-2010 will include both oral and poster presentations from academic and industrial settings. We hope to set a stage for all the medical doctors, the academicals, the clinical and the industrial researchers to make your research and innovations known with equal opportunity, means to join this event actively. The capital city, Beijing has long been the political, cultural, scientific and diplomatic center of China. It is both a tribute to China's proud history and a gateway to China's future. Beijing Olympics brought the world a great surprise for the Olympics opening ceremony, WCIT-2010 will be held in Beijing International Convention Center (BICC) which located very near to The National Olympic Sports Center, it's a great advantage to see this amazing place. Also, May is the most pleasant season in spring, you are encourage to have lecture tour to other cities in China. We look forward to seeing you in Beijing for a stimulating and enjoyable conference! Below is the program track info. Kayla Liu Program Coordinator The Organizing Committee of WCIT-2010 Tentative Program Symposium 1: Research Frontiers on Immune Diseases Session 1-1: The Immunity Diseases Molecular Mechanisms Session 1-2: Immunopathology, Etiology and Pathogenic Role of Complement Session 1-3: Genetics of Immune and Autoimmunity Diseases Session 1-4: Cell and Molecular Biology of Autoimmunity Session 1-5: Tumor Immunology Session 1-6: Innate to Acquired (Adaptive) Immunity and Diseases Session 1-7: Toll-like Receptors and Pattern Recognition Receptors Session 1-8: Immune Signal Transduction and Cross-talk Session 1-9: Immune Regulations- Regulatory T Cells and T Cell Subsets Session 1-10: Dendritic Cells, Macrophages and other Innate Immune Cells Session 1-11: Human Immunology and Immunodeficiencies Session 1-12: Hypersensitivity, Antigen Processing and Presentation Session 1-13: Immunological Inflammations and Vascular Injury Session 1-14: Neuroimmunology, Neuroendocrine Immunology and Psychoneuroimmunology Session 1-15: Natural Killer Cells, Apoptosis & Immunity Session 1-16: Infection and Immunity, Epidemiology of Immune Diseases Session 1-17: Prophylaxis and Intervention Session 1-18: Mucosal Immunology Session 1-19: Immunochemistry & Immunobiology Session 1-20: Immune Tolerance in Autoimmune Disease Symposium 2: Leading Technologies in Immunology Session 2-1: System Biology and Computational Immunology Session 2-2: Hybridoma Technology Session 2-3: Sensitivity and Accuracy in Imaging Immunity Session 2-4: Immunogenomics & Immunoproteomics Session 2-5: Biochips, Microarray Based Technology Session 2-6: New Immune Intervention Technologies Session 2-7: Small RNAs in Development and Immune Diseases Session 2-8: Nucleic Acids in Innate Immunity Session 2-9: The Stem Cells and Implications in Immune Diseases Session 2-10: The SCID Mouse as Model of Immune Diseases Symposium 3: Immune Disease Drug Discovery & Development Session 3-1: Molecular Targets and Biomarkers of Immunotherapeutics Session 3-2: Computer Aided Drug Design & Medicinal Chemistry Session 3-3: Immunopharmacology Session 3-4: Immunosuppression and Immunotherapy Development Session 3-5: Cytokines, Chemokine and Cell Adhesion Molecules and Drug Discovery Session 3-6: Gene and Cell Therapy Session 3-7: Monoclonal Antibody and Antibody Engineering Session 3-8: Innate Immunity and Novel Vaccines Session 3-9: Novel Drug Delivery Systems of Immunotherapeutics Session 3-10: Traditional Medicines for Immune and Inflammatory Diseases Symposium 4: Medical Research and Immune Diseases Session 4-1: Immunity and Emerging Infectious Disease Session 4-2: Hormones and Immune Response Mediated Diseases Session 4-3: Allergy, Asthma & Clinical Immunology Session 4-4: Autoimmunity Mediated Diseases Session 4-5: Lymphocyte Development and Functions in Immune Diseases Session 4-6: Immunosenescence and Clinical Applications Session 4-7: Immunity and Aging Session 4-8: Reproductive Immunology Session 4-9: Neonatal and Maternal Immunization Session 4-10: Translational Immunology Symposium 5: Diagnostics & Immunotherapy of Major Diseases Session 5-1: Biomarkers for Molecular Diagnostics of Immune Diseases Session 5-2: Insulin-Dependent Diabetes Mellitus Session 5-3: Allergy, Asthma and Rheumatoid Arthritis Session 5-4: Inflammatory Bowel Disease and Ocular Inflammation Session 5-5: Vasculitis and Cardiovascular Diseases Session 5-6: Lung Inflammation and Fibrosis Session 5-7: Autoimmune Hepatitis and Chronic Liver Diseases Session 5-8: Multiple Sclerosis, Scleroderma, Myasthenia Gravis, and Neuromuscular Diseases Session 5-9: Systemic Lupus Erythematosus and and Other Connective Tissue Diseases Session 5-10: Psoriasis, Allergic Skin Diseases and Immunodermatology Session 5-11: Immunotherapy on Reemerging TB and Malaria Session 5-12: Immunological Renal Diseases, and Organ Transplant Rejection Session 5-13: Major Cancers- Breast Cancer Session 5-14: Major Cancers-Head, Brain and Neck Cancers Session 5-15: Major Cancers- Cervical and Ovarian Cancer Session 5-16: Major Cancers- Pancreatic , Prostate, and Renal Cancer Session 5-17: Major Cancers- Leukemia, Lymphoma & Melanoma Session 5-18: Major Cancers- Lung Cancer Session 5-19: Major Infectious Diseases- HIV/AIDS and Other Viral Infections Session 5-20: Major Infectious Diseases-Resistant Bacterial Infections Symposium 6: Benchmark Analysis and Case Studies Session 6-1: Anticancer Drugs Session 6-2: Anti-inflammatory Drugs Session 6-3: Anti-allergy and Asthma Drugs Session 6-4: Anti-Infectious Drugs Session 6-5: Anti-Autoimmune Drugs http://www.mymedicalcareer.com.au/news/2009/09/bit-life-sciences-1st-annual-w-1/ http://www.mymedicalcareer.com.au/news/2009/09/bit-life-sciences-1st-annual-w-1/ News & Events immunodiseases Tue, 29 Sep 2009 19:33:44 +1000

Community Preparedness & Context

Early Interventions

Medium Term Interventions

Long Term Interventions

Stream Topics:

• Emergency Services & Administration
• Mental Health Services Delivery
• Development of Individual and Community Resilience

Invited Speakers Include:

• Prof Peg Le Vine, Professor of Psychosocial Health, Monash Asia Institute confirmed
• A/Prof Sabina Knight, Director, Rural Health Education Foundation, Senior Lecturer at Centre of Remote Health confirmed
• Prof Gavin Andrews, UNSW at St Vincent's Hospital confirmed
• Assoc Professor Dennis Pashen, Mount Isa Centre for Rural and Remote Health
• Prof Beverley Raphael, Professor & Head of Psychological Medicine, Australian National University, Professor of Population Mental Health and Disasters and Director of the Centre for Disasters and Terrorism (DAT) at the University of Western Sydney confirmed
• Dr Helen J. Stain Senior Lecturer, Clinical Psychologist, Centre for Rural and Remote Mental Health, University of Newcastle confirmed
• Professor Don Gorman, Director, Centre for Rural & Remote Area Health, University of Southern Queensland, Toowoomba confirmed
• Dr Keith Miller, BSc (Adel), BTh(Hons), BSocPlan (Hons), BSW, PhD, Lecturer, Flinders University confirmed
• Dr. Dennis Pashen, President, Australian College of Rural and Remote Medicine confirmed

]]> http://www.mymedicalcareer.com.au/news/2009/09/1st-australian-rural-and-remot/ http://www.mymedicalcareer.com.au/news/2009/09/1st-australian-rural-and-remot/ News & Events mental health rural and remote health symposium Sun, 13 Sep 2009 10:43:38 +1000

identify factors that chief residents believe impact the teaching of junior residents under normal working conditions and

the areas in which they believe education on the role of resident as teacher would be beneficial.

]]> http://www.mymedicalcareer.com.au/news/2009/09/obstetrics-and-gynaecology-chi/ http://www.mymedicalcareer.com.au/news/2009/09/obstetrics-and-gynaecology-chi/ News & Events gynaecology obstetrics Fri, 11 Sep 2009 10:35:42 +1000 MEDIA RELEASE 25th August 2009 Tasmania Ambulance first to use new life-saving technology The Tasmanian Ambulance Service is the first state service in Australia to trial the internationally acclaimed life-saving device the ResQPOD which uses ‘Impedance Threshold Device’ technology. A simple, non-invasive device that fits in the palm of the hand, the ResQPOD quickly and effectively increases circulation and blood flow to the brain and when used in conjunction with cardiopulmonary resuscitation (CPR) helps supply more blood to the heart during the process. Sudden cardiac arrest is the leading cause of death among adults worldwide. Experienced by over million people annually more than 95% of victims do not survive despite receiving CPR, as at best it can deliver only 25% of normal blood flow to the brain and 15% of normal blood flow to the heart. The ResQPOD utilises Impedance Threshold Device (ITD) technology, which increases circulation flow to vital organs in states of low blood flow such as in a Cardiac Arrest. It works by enhancing the vacuum created during the decompression phase of chest compressions which increases the return of blood to the heart and therefore increases the amount of blood push out from the heart during the compression phase of chest compression. The device can be used in Basic Life Support by attaching it to a simple resuscitation mask or used in Advanced Life Support by attaching it to advanced airway devices. Already in use at more than 1,500 hospitals and emergency management systems across the U.S. the ResQPOD has also proved successful across Europe, the Middle East and Hong Kong, Singapore and The Philippines and been used by industry in Australia for some months. Emergency services personnel worldwide are reporting a dramatic overall increase in their ability to ‘get back a pulse’ and more significantly increase the rates of ‘neurologically intact’ hospital discharge. More … Dr. Susannah Sherlock, Medical Director for Tasmanian Ambulance Services is excited to be trialing the device. “I am pleased to be able to trial the use of the Impedance Threshold Device with the Tasmanian Ambulance Service,” she said. “The European Resuscitation Guidelines 2005 have indicated it may be of great benefit in cardiac arrest”. The ResQPOD is also recognised by the American Heart Association as the only technology to be given a Class IIa recommendation (the second highest class) in its guidelines for purposes of increasing circulation and resuscitation rates ahead of any other intervention required in cardiac arrest situations, including widely used drug therapies. Charles Makray, Director of First Response Australia, provider of emergency medical response courses and equipment, trains clients in the use of the ResQPOD which has already resulted in the saving of a life by an aviation rescue service in Victoria. “Increasing blood flow to the heart and brain until the heart can be restarted is critical to improving survival rates with normal neurological functioning,” Mr Makray said. “The ResQPOD doubles both blood flow to the heart and systolic blood pressure, allowing more effective circulation of drugs, increasing the likelihood of successful defibrillation and ultimately increasing the survival rate of the patient.” A related product, soon to be released in Australia, the ResQGard(TM), utilises the same ITD technology and is used to help improve blood flow and circulation in breathing patients that are suffering from low blood pressure as a result of traumatic injuries, shock, dehydration, dialysis and orthostatic intolerance. For further information contact: Charles Makray, First Response Australia ph: (07) 4032-2444 Go to www.resqpod.com.au http://www.mymedicalcareer.com.au/news/2009/08/tasmanian-ambulance-first-to-u/ http://www.mymedicalcareer.com.au/news/2009/08/tasmanian-ambulance-first-to-u/ News & Events Tue, 25 Aug 2009 14:40:08 +1000 The 1st Australian Rural & Remote Mental Health Symposium being held at the National Convention Centre, Canberra from 2nd - 3rd November. The recent incidents of natural disaster in Victoria (bushfires) and Queensland (floods, cyclones, oil spills) have left a trail of death and destruction, shattered communities, and displaced people. Such events severely impact on the Mental Health of individual survivors, and impact on community functioning. What lessons can be learned from our response to these events? How can Mental Health professionals prepare themselves more effectively to deal with such events in rural and remote communities? How can the resources of Government, mental health professionals, emergency services, and private practitioners be better utilised for optimal benefit? What long term planning is required to provide ongoing support, treatment and infrastructure? Can our response to recent disasters provide the roadmap to build capacity in rural and remote areas? Themes: Community Preparedness & Context Early Interventions Medium Term Interventions Long Term Interventions Stream Topics: Emergency Services & Administration Mental Health Services Delivery Development of Individual and Community Resilience Confirmed Keynote Presenters include: Prof Beverley Rachael - University of Western Sydney Dr Helen Stain - University of Newcastle Prof Don Gorman - University of Southern Queensland A/Prof Sabina Knight - Centre for Remote Health in Alice Springs Prof Peg Le Vine - Monash University Prof Gavin Andrews - University of New South Wales Dr Keith Miller - Flinders University http://www.mymedicalcareer.com.au/news/2009/08/1st-australian-rural-remote-me/ http://www.mymedicalcareer.com.au/news/2009/08/1st-australian-rural-remote-me/ News & Events Wed, 12 Aug 2009 17:07:33 +1000